KRT84

gene
On this page

Also known as Hb-4

Summary

KRT84 (keratin 84, HGNC:6461) is a protein-coding gene on chromosome 12q13.13, encoding Keratin, type II cuticular Hb4 (Q9NSB2).

The protein encoded by this gene is a member of the keratin gene family. As a type II hair keratin, it is a basic protein which heterodimerizes with type I keratins to form hair and nails. The type II hair keratins are clustered in a region of chromosome 12q13 and are grouped into two distinct subfamilies based on structure similarity. One subfamily, consisting of KRTHB1, KRTHB3, and KRTHB6, is highly related. The other less-related subfamily includes KRTHB2, KRTHB4, and KRTHB5. All hair keratins are expressed in the hair follicle; this hair keratin is contained primarily in the filiform tongue papilla, among other hair keratins.

Source: NCBI Gene 3890 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 126 total
  • MANE Select transcript: NM_033045

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6461
Approved symbolKRT84
Namekeratin 84
Location12q13.13
Locus typegene with protein product
StatusApproved
AliasesHb-4
Ensembl geneENSG00000161849
Ensembl biotypeprotein_coding
OMIM602766
Entrez3890

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000257951

RefSeq mRNA: 1 — MANE Select: NM_033045 NM_033045

CCDS: CCDS8825

Canonical transcript exons

ENST00000257951 — 9 exons

ExonStartEnd
ENSE000009198855237781252378380
ENSE000009198865237987652379907
ENSE000009198875238036352380583
ENSE000009198885238108052381205
ENSE000009198905238243752382532
ENSE000009198925238359052383798
ENSE000009198935238504052385652
ENSE000016951065238136152381525
ENSE000017389005238300552383065

Expression profiles

Bgee: expression breadth broad, 21 present calls, max score 42.46.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6548 / max 815.9880, expressed in 8 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1310270.65488

Top tissues by expression

122 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
placentaUBERON:000198742.46gold quality
tonsilUBERON:000237240.24gold quality
skin of abdomenUBERON:000141639.46gold quality
prefrontal cortexUBERON:000045138.63silver quality
zone of skinUBERON:000001437.67gold quality
colonic epitheliumUBERON:000039737.20gold quality
skin of legUBERON:000151136.53gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
hindlimb stylopod muscleUBERON:000425235.54gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113434.74gold quality
frontal cortexUBERON:000187034.73silver quality
vaginaUBERON:000099633.31gold quality
superior frontal gyrusUBERON:000266132.62gold quality
muscle tissueUBERON:000238532.06gold quality
cerebral cortexUBERON:000095631.89gold quality
bone marrowUBERON:000237131.74gold quality
dorsolateral prefrontal cortexUBERON:000983431.08gold quality
sural nerveUBERON:001548830.93gold quality
anterior cingulate cortexUBERON:000983530.09gold quality
stromal cell of endometriumCL:000225529.87gold quality
urinary bladderUBERON:000125529.55gold quality
monocyteCL:000057629.54gold quality
leukocyteCL:000073829.36gold quality
liverUBERON:000210729.25gold quality
right frontal lobeUBERON:000281029.17gold quality
ectocervixUBERON:001224928.60gold quality
spleenUBERON:000210628.15gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.47

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

10 targeting KRT84, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-807399.8665.211118
HSA-MIR-221-5P99.8665.451052
HSA-MIR-486-3P99.5166.821901
HSA-MIR-6868-5P99.0665.691284
HSA-MIR-942-3P98.8169.04876
HSA-MIR-1227-5P98.6565.321549
HSA-MIR-3135B98.6165.331470
HSA-MIR-4691-5P98.4166.771343
HSA-MIR-6792-3P98.4166.861359
HSA-MIR-22-5P97.6768.921355

Literature-anchored findings (GeneRIF, showing 1)

  • KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma. (PMID:32181476)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusKrt84ENSMUSG00000044294
rattus_norvegicusKrt84ENSRNOG00000008819

Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360), KRT13 (ENSG00000171401)

Protein

Protein identifiers

Keratin, type II cuticular Hb4Q9NSB2 (reviewed: Q9NSB2)

Alternative names: Keratin-84, Type II hair keratin Hb4, Type-II keratin Kb24

All UniProt accessions (1): Q9NSB2

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Heterotetramer of two type I and two type II keratins.

Tissue specificity. Expressed in the hair follicles.

Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).

Similarity. Belongs to the intermediate filament family.

RefSeq proteins (1): NP_149034* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003054Keratin_IIFamily
IPR018039IF_conservedConserved_site
IPR032444Keratin_2_headDomain
IPR039008IF_rod_domDomain

Pfam: PF00038, PF16208

UniProt features (19 total): region of interest 7, sequence variant 5, sequence conflict 5, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NSB2-F168.520.45

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology

MSigDB gene sets: 84 (showing top): GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT, GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_APPENDAGE_DEVELOPMENT, HFH8_01, FOXJ2_01, GOBP_MOLTING_CYCLE, GOBP_EPIDERMIS_DEVELOPMENT, AFP1_Q6, GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION, FOXJ2_02, GOBP_KERATINIZATION

GO Biological Process (5): hair follicle development (GO:0001942), keratinization (GO:0031424), nail development (GO:0035878), intermediate filament organization (GO:0045109), regulation of keratinocyte differentiation (GO:0045616)

GO Molecular Function (2): structural constituent of cytoskeleton (GO:0005200), structural constituent of skin epidermis (GO:0030280)

GO Cellular Component (5): cytosol (GO:0005829), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882), intermediate filament cytoskeleton (GO:0045111)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Developmental Biology1
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
anatomical structure development2
keratinocyte differentiation2
structural molecule activity2
cytoskeleton2
hair cycle process1
skin epidermis development1
multicellular organismal process1
limb development1
intermediate filament cytoskeleton organization1
supramolecular fiber organization1
regulation of epidermal cell differentiation1
cytoskeleton organization1
cytoplasm1
cellular anatomical structure1
intermediate filament1
extracellular vesicle1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

910 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRT84KRTAP3-1Q9BYR8520
KRT84OR6X1Q8NH79506
KRT84KRTAP13-1Q8IUC0500
KRT84HOXC13P31276489
KRT84DSG4Q86SJ6453
KRT84SELENBP1Q13228426
KRT84AKR1B10O60218424
KRT84MEPCEQ7L2J0424
KRT84LY6DQ14210413
KRT84SPRR4Q96PI1398
KRT84KRTAP19-7Q3SYF9392
KRT84PRSS53Q2L4Q9388
KRT84STARD9Q9P2P6383
KRT84PRR9Q5T870375
KRT84OR13J1Q8NGT2375

IntAct

14 interactions, top by confidence:

ABTypeScore
NEURL4APBB1psi-mi:“MI:0914”(association)0.530
STARD8JPH1psi-mi:“MI:0914”(association)0.530
CFTRCNOT1psi-mi:“MI:0914”(association)0.480
METTL3TUBAL3psi-mi:“MI:0914”(association)0.350
CUL3PXDNLpsi-mi:“MI:0914”(association)0.350
SLX1APSMD11psi-mi:“MI:0914”(association)0.350
USP37ALBpsi-mi:“MI:0914”(association)0.350
KATNIPpsi-mi:“MI:0914”(association)0.350
CFTRPOTEFpsi-mi:“MI:0914”(association)0.350
SULF2IGHA1psi-mi:“MI:0914”(association)0.350
ARMC9PRMT5psi-mi:“MI:0914”(association)0.350
NRASIGKV2D-24psi-mi:“MI:0914”(association)0.350
FHIP2AMED19psi-mi:“MI:2364”(proximity)0.270

BioGRID (51): KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-RNA), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS)

ESM2 similar proteins: A0JND2, A3KN27, A5A6N0, A6BLY7, A6H712, A6QNX5, A7YWK3, E1AB55, P07744, P08729, P19013, P25691, Q0P5J4, Q0P5J6, Q0P5J7, Q0VBK2, Q148H5, Q148H6, Q148H7, Q148H8, Q14CN4, Q3SY84, Q5XKE5, Q64291, Q6IFW8, Q6IFZ9, Q6IG00, Q6IG01, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6IMF1, Q6KB66, Q6NXH9, Q6R649, Q7RTS7, Q7Z3Y7, Q7Z3Y9, Q7Z794

Diamond homologs: A0A8C0N8E3, A0JND2, A3KN27, A4FUZ0, A5A6M6, A5A6M8, A5A6N0, A6QNX5, A6QQJ3, A7YWK3, E1AB55, O43790, O93532, O95678, P02538, P04104, P04259, P04264, P04265, P04266, P05786, P05787, P07744, P08670, P08729, P08776, P11679, P12035, P13647, P15241, P15331, P16878, P18520, P19013, P21807, P25691, P35908, P41219, P48616, P48668

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

126 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance114
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1088 predictions. Top by Δscore:

VariantEffectΔscore
12:52379874:A:ACdonor_gain1.0000
12:52379875:C:CCdonor_gain1.0000
12:52380355:GTACT:Gdonor_loss1.0000
12:52380357:ACT:Adonor_loss1.0000
12:52380359:TCA:Tdonor_loss1.0000
12:52380360:CA:Cdonor_loss1.0000
12:52380361:A:ACdonor_gain1.0000
12:52380361:A:Tdonor_loss1.0000
12:52380361:AC:Adonor_gain1.0000
12:52380361:ACCGG:Adonor_gain1.0000
12:52380362:C:CGdonor_gain1.0000
12:52380362:CC:Cdonor_gain1.0000
12:52380362:CCGG:Cdonor_gain1.0000
12:52380362:CCGGC:Cdonor_gain1.0000
12:52380580:CACG:Cacceptor_gain1.0000
12:52380582:CG:Cacceptor_gain1.0000
12:52380584:C:CCacceptor_gain1.0000
12:52381075:CCCA:Cdonor_loss1.0000
12:52381076:CCACC:Cdonor_loss1.0000
12:52381077:CACCT:Cdonor_loss1.0000
12:52381078:A:Cdonor_loss1.0000
12:52381079:C:CTdonor_loss1.0000
12:52381105:G:GAdonor_gain1.0000
12:52381110:AAG:Adonor_gain1.0000
12:52381201:TCATA:Tacceptor_gain1.0000
12:52381202:CATA:Cacceptor_gain1.0000
12:52381202:CATAC:Cacceptor_gain1.0000
12:52381203:ATA:Aacceptor_gain1.0000
12:52381204:TA:Tacceptor_gain1.0000
12:52381206:C:CCacceptor_gain1.0000

AlphaMissense

3920 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:52385058:A:CF176L0.987
12:52385058:A:TF176L0.987
12:52385060:A:GF176L0.987
12:52383008:C:AK271N0.977
12:52383008:C:GK271N0.977
12:52385059:A:CF176C0.964
12:52385059:A:GF176S0.963
12:52383779:T:GQ189P0.957
12:52385068:T:AN173I0.954
12:52383020:A:CF267L0.953
12:52383020:A:TF267L0.953
12:52383022:A:GF267L0.953
12:52380422:C:AK455N0.950
12:52380422:C:GK455N0.950
12:52383794:C:GR184P0.950
12:52385067:G:CN173K0.949
12:52385067:G:TN173K0.949
12:52383782:T:GQ188P0.939
12:52385049:G:CF179L0.939
12:52385049:G:TF179L0.939
12:52385051:A:GF179L0.939
12:52385071:A:GL172P0.938
12:52380384:A:GL468P0.932
12:52383784:C:AE187D0.926
12:52383784:C:GE187D0.926
12:52381384:C:GA352P0.925
12:52382458:A:CF297L0.925
12:52382458:A:TF297L0.925
12:52382460:A:GF297L0.925
12:52385056:G:TA177D0.925

dbSNP variants (sampled 300 via entrez): RS1000421639 (12:52379415 T>A), RS1001134522 (12:52379676 C>A), RS1001315457 (12:52380224 C>A), RS1001688382 (12:52380752 ATGGGGTAGGGCAT>A), RS1002026991 (12:52379588 G>C), RS1002566716 (12:52383876 A>G), RS1002637652 (12:52385274 AC>A,ACC), RS1002704386 (12:52377879 G>T), RS1002720110 (12:52388902 G>A,T), RS1002819919 (12:52380278 A>G), RS1002898668 (12:52387697 T>G), RS1002939648 (12:52388677 G>T), RS1003022482 (12:52382720 G>A,T), RS1003195648 (12:52383703 G>A), RS1003232261 (12:52386677 T>C)

Disease associations

OMIM: gene MIM:602766 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases expression1
Benzo(a)pyreneincreases methylation1
Caffeinedecreases expression1
Phenolsulfonphthaleinaffects cotreatment, increases expression1
Tetrachlorodibenzodioxindecreases expression1
Aflatoxin B1decreases methylation1
Cadmium Chlorideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.